Compounds > 1-phenyl-2-decanoylamino-3-morpholino-1-propanol

1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Glioma

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with Glioma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrier, L; Ingrand, S; Noel, A	1

Other Studies

1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Glioma

Article	Year
Inhibition of GSK3β by pharmacological modulation of sphingolipid metabolism occurs independently of ganglioside disturbance in a cellular model of Alzheimer's disease. Experimental neurology, 2015, Volume: 271 Topics: Amyloid beta-Protein Precursor; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Gangliosides; Gene Expression Regulation, Enzymologic; Glioma; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Hypoglycemic Agents; Insulin; Morpholines; Mutation; Signal Transduction; Sphingolipids; Time Factors	2015

Article

Year

Inhibition of GSK3β by pharmacological modulation of sphingolipid metabolism occurs independently of ganglioside disturbance in a cellular model of Alzheimer's disease.

Experimental neurology, 2015, Volume: 271

Topics: Amyloid beta-Protein Precursor; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Gangliosides; Gene Expression Regulation, Enzymologic; Glioma; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Hypoglycemic Agents; Insulin; Morpholines; Mutation; Signal Transduction; Sphingolipids; Time Factors

2015